There is something I have been hearing quite often lately from people who come to the clinic with cystitis: "Please give me that medicine I used to take; when I took it, I got better right away." But cases where the same class of medicine does not clear it up as well as before have increased. It is not that the medicine was wrongly prescribed, nor that the body has weakened. It is because the antibiotic resistance pattern of the bacteria that cause cystitis itself has changed over the past dozen years or so, and the medication recommended as first-line has changed accordingly. In this article, I will carefully go over why prescriptions have changed and when a culture test is needed.
Cystitis is mostly caused by E. coli
The most common causative organism of simple cystitis is E. coli. Bacteria that normally live in the intestine ascend through the urethra into the bladder, causing inflammation and producing symptoms such as frequent urination, painful urination, and a sense of residual urine. Women are known to be more vulnerable to cystitis because of the anatomical feature of a short urethra close to the anus.
The important point here is the direction of treatment. Cystitis is not "a disease that heals if you use any antibiotic" but "a disease where you choose the medicine that actually works well against E. coli." Even with the same antibiotic, the effect greatly varies depending on how well the E. coli of that region and that time responds (susceptibility). So the key to cystitis treatment lies not in the "strength" of the medicine but in "a choice matched to susceptibility." In the clinic, just understanding this difference can greatly reduce unnecessary medication changes and return visits. If you are curious about the basic principles of cystitis, the article on the causes and treatment of cystitis, with painful and stinging urination covers it in more detail.
Why have prescriptions changed: the variable of resistance
The most direct reason antibiotic prescriptions have changed is the increase in E. coli resistance. When antibiotics are used often and more than necessary, the bacteria that survive that medicine gradually increase. When these surviving organisms cause the next infection, the medicine that used to work well no longer works.
What became particularly problematic is the quinolone class (representatively ciprofloxacin). It was once the most commonly prescribed medicine for cystitis, but in domestic and overseas surveillance data, the quinolone susceptibility of E. coli has been reported to steadily decline. The U.S. Food and Drug Administration, through a 2016 safety letter, recommended not using quinolones as first-line when other treatment options exist, as in simple urinary tract infection, and leaving them for when there is no alternative medicine, and afterward it added warnings about tendon-, nerve-, and blood-vessel-related adverse reactions.
Antibiotics are not just one person's problem. A single unnecessary prescription grows the resistant strains of the entire community, and ultimately reduces the medicine available at the very moment it is needed. That is why "using less but using properly" antibiotic stewardship is emphasized.
The recurrent urinary tract infection guideline jointly issued by the American Urological Association and the Canadian Urological Association and others (2019, reaffirmed in 2022) likewise emphasizes, in the same vein, antibiotic stewardship that reduces broad-spectrum antibiotic use and matches necessary treatment to the minimum effective duration.
Medicines that still work well and medicines that have become cautious
So which medicines are currently preferred for simple cystitis, and which have become cautious? Organizing the trend appearing in domestic surveillance data in broad terms gives the following. It is better to understand it as a "tendency" than as specific figures.
| Category | Representative medicine | Recent trend |
|---|---|---|
| Medicine that works relatively stably | Nitrofurantoin, fosfomycin | Tends to be maintained relatively stably as an option for empirical treatment of simple cystitis |
| Medicine that has become cautious | Quinolone class, TMP-SMX | With increased resistance, the possibility of failure may rise if used without testing |
The reason nitrofurantoin and fosfomycin are often considered first-line is that they work relatively steadily against the E. coli that causes simple cystitis while not being much used for infections in other sites, so there is little resistance pressure. The simple cystitis guideline jointly issued by the Infectious Diseases Society of America and the European Society of Clinical Microbiology and Infectious Diseases also presents nitrofurantoin, fosfomycin, and TMP-SMX—when the local E. coli resistance rate is below a certain level—as first-line choices. Conversely, the quinolone and beta-lactam classes are classified as alternative medicines.
Antibiotics do not heal faster the stronger you use them
One of the most frequent misunderstandings I receive in the clinic is the request "if anything, finish it quickly with a strong medicine." In clinical experience, this idea often has the opposite effect.
The goal of cystitis treatment is not to overwhelm the bacteria with a powerful medicine but to use the medicine that works precisely against the causative organism for an appropriate duration. Habitually using broad-spectrum, strong antibiotics can shake even the normal bacterial flora and bring other side effects, and above all grows resistance more. The recommended medicines and durations can be organized roughly as follows.
- Nitrofurantoin: usually taken for about 5 days in many cases
- Fosfomycin: usually ends with a single one-time dose in many cases
The key is choice and duration. Using a medicine that works well only as much as needed is the path that raises the treatment success rate while growing resistance less. As for the dosing period, keeping the recommended duration rather than arbitrarily shortening it because symptoms improved helps reduce the risk of recurrence and resistance. However, if there are side effects such as a rash or gastrointestinal trouble during use, please consult the medical team before stopping.
For a more detailed explanation of how many days you should take the medicine, refer to the article on how many days cystitis antibiotics should be taken. If you are curious whether the prescribed medicine works well, or symptoms are ambiguous, you can consult comfortably via inquire about cystitis symptoms via chat.
In these cases, a culture test is the shortcut to treatment
Not every cystitis needs a culture test. Typical simple cystitis is often started empirically on a first-line medicine without testing. However, in the following situations, a urine culture test that confirms the causative organism and susceptibility before switching to a "stronger medicine" is actually a faster and more accurate path.
- When symptoms do not improve even after taking antibiotics for 48–72 hours
- When it is recurrent, with cystitis repeating at short intervals
- When cystitis is suspected during pregnancy
- When high fever or flank pain accompanies it and pyelonephritis is suspected
- When there is a possibility of complicated urinary tract infection due to stones, urinary tract malformation, immunosuppression, etc.
In such cases, switching medicines without knowing which medicine works can waste time and only grow resistant organisms. Confirming the organism directly and choosing the medicine that matches is, in the end, faster. If cystitis keeps coming back, I recommend also examining the lifestyle-habit check for recurring cystitis. If you are in a situation needing testing for recurrent urinary symptoms, you can check the care flow at the cystitis symptom care guide.
A summary of frequently asked questions
I have gathered and organized the questions that repeatedly come up in the clinic about the change in cystitis prescriptions.
Can't I just ask for the medicine I took before that worked well?
At that time, it is highly likely you were lucky and the susceptibility to that medicine matched. However, recently, resistance has increased centered on the quinolone class, so if you use the same medicine empirically without testing, the possibility of failure may be higher than before. It is safer to judge the medicine again according to symptoms and medical history.
Can I stop the medicine once symptoms improve?
Even if symptoms disappear, the organism may not be completely cleared. It is reported that keeping the recommended dosing period helps reduce the risk of recurrence and resistance. If there are side effects, consult the medical team before stopping on your own.
My cystitis recurs often—do I have to take antibiotics every time?
If recurrence is frequent, rather than repeating the same empirical prescription every time, an approach that confirms the causative organism and susceptibility and examines lifestyle habits and contributing factors together is recommended. Recurrent urinary tract infection may need a separate management strategy.
In closing
These days, the baseline of treatment for simple cystitis has changed because of the change in E. coli resistance. Nitrofurantoin and fosfomycin are still considered first-line, while the quinolone class has become more cautious in empirical treatment. And when it recurs, treatment fails, or pregnancy or complicated infection is suspected, finding the right medicine with a culture test rather than seeking a stronger medicine is the fastest path. If there is high fever, flank pain, vomiting, or severe hematuria, examination is needed without delay. If your symptoms are confusing or you are weighing whether to switch medicine, please try to consult about cystitis symptoms via chat.
Written by: Lee Dong-hee Director · Obstetrics and Gynecology Specialist · View medical staff profile
First published February 9, 2026 · Last reviewed May 30, 2026
References: Infectious Diseases Society of America / European Society of Clinical Microbiology and Infectious Diseases Simple Cystitis/Pyelonephritis Guidelines (2010, 2011), American/Canadian Urological Association Recurrent Urinary Tract Infection Guidelines (2019, 2022), U.S. Food and Drug Administration Quinolone Safety Letters (2016, 2018)
This article is intended to provide general health information and does not replace individual diagnosis or treatment. If you have symptoms, please consult through an examination.